Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009

Journal of Bone and Joint Surgery

Volumn 96, Issue 7, 2014, Pages e52(1)-

  Balasubramanian, Akhila ^a   Tosi, Laura L ^b   Lane, Joseph M ^c   Dirschl, Douglas R ^d   Ho, Pei Ran ^a   O'Malley, Cynthia D ^a  

^a AMGEN INC   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; IBANDRONIC ACID; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; ZOLEDRONIC ACID;

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HIP; HIP FRACTURE; HUMAN; HUMERUS; HUMERUS FRACTURE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PAGET BONE DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPINE FRACTURE; UNITED STATES; VERTEBRA; WRIST; WRIST FRACTURE;

ABSORPTIOMETRY, PHOTON; AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; SECONDARY PREVENTION; UNITED STATES;

EID: 84898450612     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.L.01781     Document Type: Article

References (36)

1. Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009 Feb 4;301(5):513-21.
2. Colón-Emeric C, Kuchibhatla M, Pieper C, Hawkes W, Fredman L, Magaziner J, Zimmerman S, Lyles KW. The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies. Osteoporos Int. 2003 Nov;14(11): 879-83. Epub 2003 Oct 03.
3. Teng GG, Curtis JR, Saag KG. Mortality and osteoporotic fractures: is the link causal, and is it modifiable? Clin Exp Rheumatol. 2008 Sep-Oct;26(5)(Suppl 51):S125-37.
4. Center JR, Bliuc D, Nguyen TV, Eisman JA. Risk of subsequent fracture after low-trauma fracture in men and women. JAMA. 2007 Jan 24;297(4):387-94. (Pubitemid 46155800)
5. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000 Apr;15(4): 721-39. (Pubitemid 30174026)
6. Taylor AJ, Gary LC, Arora T, Becker DJ, Curtis JR, Kilgore ML, Morrisey MA, Saag KG, Matthews R, Yun H, Smith W, Delzell E. Clinical and demographic factors associated with fractures among older Americans. Osteoporos Int. 2011 Apr;22(4): 1263-74. Epub 2010 Jun 18.
7. Warriner AH, Patkar NM, Yun H, Delzell E. Minor, major, low-trauma, and high-trauma fractures: what are the subsequent fracture risks and how do they vary? Curr Osteoporos Rep. 2011 Sep;9(3):122-8.
8. Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE. Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int. 2004 Oct;15(10):767-78. Epub 2004 Jul 16.
9. Teng GG, Warriner A, Curtis JR, Saag KG. Improving quality of care in osteoporosis: opportunities and challenges. Curr Rheumatol Rep. 2008 Apr;10(2): 123-30.
10. Cramer JA, Gold DT, Silverman SL, Lewiecki EM. A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int. 2007 Aug;18(8):1023-31. Epub 2007 Feb 17.
11. Kothawala P, Badamgarav E, Ryu S, Miller RM, Halbert RJ. Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc. 2007 Dec;82(12):1493-501. (Pubitemid 350211697)
12. Siris ES, Harris ST, Rosen CJ, Barr CE, Arvesen JN, Abbott TA, Silverman S. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc. 2006 Aug;81(8):1013-22. (Pubitemid 44175011)
13. Siris ES, Selby PL, Saag KG, Borgström F, Herings RM, Silverman SL. Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. Am J Med. 2009 Feb;122(2)(Suppl):S3-13.
14. U.S. Department of Health and Human Services, Office of the Surgeon General. Bone health and osteoporosis: A report of the surgeon general. 2004. http://www.surgeongeneral.gov/library/bonehealth/content.html. Accessed 2012 May 27.
15. National Committee for Quality Assurance. The state of health care quality 2011. Continuous improvement and the expansion of quality measurement. 2011. http://www.ncqa.org/LinkClick.aspx?fileticket=J8kEuhuPqxk%3d&tabid= 836. Accessed 2012 May 27.
16. National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. 2013. http://nof.org/files/nof/public/content/ resource/913/files/580.pdf. Accessed 2013 Jul 19.
17. The International Society for Clinical Densitometry. 2007 Official positions of the International Society for Clinical Densitometry. 2007. http://www.iscd.org/wp-content/themes/iscd/pdfs/official-positions/ ISCD2007OfficialPositions-Adult. pdf. Accessed 2013 July 19.
18. Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, Kleerekoper M, Luckey MM, McClung MR, Pollack RP, Petak SM; AACE Osteoporosis Task Force. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract. 2010 Nov-Dec;16(Suppl 3):1-37.
19. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause. 2010 Jan-Feb;17(1):25-54; quiz 55-6.
20. FRAX WHO fracture risk assessment tool. http://www.shef.ac.uk/FRAX/. Accessed 2013 Sep 11.
21. Tosi LL, Gliklich R, Kannan K, Koval KJ. The American Orthopaedic Association's "own the bone" initiative to prevent secondary fractures. J Bone Joint Surg Am. 2008 Jan;90(1):163-73.
22. Dell R. Fracture prevention in Kaiser Permanente Southern California. Osteoporos Int. 2011 Aug;22(Suppl 3):457-60. Epub 2011 Aug 17.
23. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992 Jun;45(6): 613-9.
24. Simonelli C, Killeen K, Mehle S, Swanson L. Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons. Mayo Clin Proc. 2002 Apr;77(4):334-8. (Pubitemid 34260741)
25. Warriner AH, Patkar NM, Curtis JR, Delzell E, Gary L, Kilgore M, Saag K. Which fractures are most attributable to osteoporosis? J Clin Epidemiol. 2011 Jan;64(1): 46-53.
26. Ettinger B, Black DM, Dawson-Hughes B, Pressman AR, Melton L J 3rd. Updated fracture incidence rates for the US version of FRAX. Osteoporos Int. 2010 Jan;21(1):25-33. Epub 2009 Aug 25.
27. Feldstein AC, Nichols GA, Elmer PJ, Smith DH, AickinM, HersonM. Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment. J Bone Joint Surg Am. 2003 Dec;85(12):2294-302. (Pubitemid 37499637)
28. Freedman KB, Kaplan FS, Bilker WB, Strom BL, Lowe RA. Treatment of osteoporosis: are physicians missing an opportunity? J Bone Joint Surg Am. 2000 Aug;82(8):1063-70. (Pubitemid 30624963)
29. Solomon DH, Finkelstein JS, Katz JN, Mogun H, Avorn J. Underuse of osteoporosis medications in elderly patients with fractures. Am J Med. 2003 Oct 1;115(5):398-400. (Pubitemid 37311258)
30. Solomon DH, Morris C, Cheng H, Cabral D, Katz JN, Finkelstein JS, Avorn J. Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc. 2005 Feb;80(2):194-202. (Pubitemid 40194534)
31. Greenspan SL, Wyman A, Hooven FH, Adami S, Gehlbach S, Anderson FA Jr, Boone S, Lacroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, Silverman S, Siris ES, Watts NB. Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women. J Am Geriatr Soc. 2012 Mar;60(3):455-61. Epub 2012 Feb 08.
32. Shepherd AJ, Cass AR, Ray LA, Tan A, Wilkinson GS. Treatment for older men with fractures. Osteoporos Int. 2012 Mar;23(3):1041-51. Epub 2011 Aug 03.
33. Feldstein A, Elmer PJ, Orwoll E, Herson M, Hillier T. Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation. Arch Intern Med 2003 Oct;163(18):2165-72. (Pubitemid 37248781)
34. Rabenda V, Vanoverloop J, Fabri V, Mertens R, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY. Low incidence of anti-osteoporosis treatment after hip fracture. J Bone Joint Surg Am. 2008 Oct;90(10):2142-8.
35. Curtis JR, Mudano AS, Solomon DH, Xi J, Melton ME, Saag KG. Identification and validation of vertebral compression fractures using administrative claims data. Med Care. 2009 Jan;47(1):69-72.
36. Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care. 1988 Aug;26(8):814-23.